Close Window

Digital Look Email A Friend

Open Orphan wins £7.3m human flu study contract

Published by Josh White on 18th May 2022

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed biotechnology company, to test its antiviral product using hVIVO's influenza human challenge study model.

URL: http://www.digitallook.com/dl/news/story/32687330/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.